The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2022 | Findings of the ISA survey on COVID-19 infection in patients with systemic amyloidosis
Paolo Milani
• 7 Sep 2022
Paolo Milani, MD, PhD, Amyloidosis Research and Treatment Center, Pavia, Italy, comments on the key results of the ISA survey on COVID-19 infection in patients with AL and ATTR amyloidosis. Overall, the survey found that the mortality rate in these cohorts is similar to that of patients with hematological malignancies. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
Disclosures
Janssen-Cilag
